Abbvie (ABBV): Anticipates its newer drugs, Skyrizi and Rinvoq, to generate a combined revenue of over $15 billion in 2025. Exxon Mobil (XOM): Tripled its share repurchase program to $30 billion through 2023. SL Green (SLG): Expects office buildings to remain in high demand by institutional investors. United Parcel Service (UPS): The guidance for 2022 projects an all-time high revenue of $102 billion Verizon Communications (VZ): Accelerating 5G deployment suggests a long-term upside due to rising data consumption.
Source: InvestorPlace
Related Articles:
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.